| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCRESAHA.109.205260 |
| P698 | PubMed publication ID | 20508201 |
| P50 | author | Akihiro Umezawa | Q86645855 |
| P2093 | author name string | Yasunori Yoshimura | |
| Kenji Miyado | |||
| Satoshi Ogawa | |||
| Nobuhiro Nishiyama | |||
| Hatsune Makino | |||
| Mamoru Tanaka | |||
| Taisuke Mori | |||
| Hironori Asada | |||
| Shunichiro Miyoshi | |||
| Junko Inoue | |||
| Kaoru Segawa | |||
| Naoko Hida | |||
| Yukinori Ikegami | |||
| Ikuko Togashi | |||
| Hikaru Nakamizo | |||
| Hiroko Tsuji | |||
| Junshi Suzuki | |||
| Masaki Satake | |||
| P2860 | cites work | Generation of germline-competent induced pluripotent stem cells | Q28131699 |
| P433 | issue | 10 | |
| P304 | page(s) | 1613-1623 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes | |
| P478 | volume | 106 |
| Q37536177 | Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia |
| Q41482454 | Amniogenic somatopleure: a novel origin of multiple cell lineages contributing to the cardiovascular system |
| Q45416548 | Amnion-derived mesenchymal stromal cells show a mesenchymal-epithelial phenotype in culture |
| Q45169663 | Amnion-derived multipotent progenitor cells support allograft tolerance induction |
| Q35155196 | Amnion-derived stem cells: in quest of clinical applications |
| Q34345679 | Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities |
| Q91806759 | Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair |
| Q36061843 | Anti-aging Effect of Transplanted Amniotic Membrane Mesenchymal Stem Cells in a Premature Aging Model of Bmi-1 Deficiency |
| Q42708757 | Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury |
| Q40394506 | Antifibrotic Effects of Human Amniotic Membrane Transplantation in Established Biliary Fibrosis Induced in Rats |
| Q36326880 | Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine |
| Q50490566 | Brief report: Misinterpretation of coculture differentiation experiments by unintended labeling of cardiomyocytes through secondary transduction: delusions and solutions |
| Q86257454 | CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro |
| Q52562669 | Cardiac Restoration Stemming From the Placenta Tree: Insights From Fetal and Perinatal Cell Biology. |
| Q37294215 | Cardiac differentiation of human pluripotent stem cells |
| Q64237444 | Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC) |
| Q47162493 | Concise Review: Fetal Membranes in Regenerative Medicine: New Tricks from an Old Dog? |
| Q35552105 | Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis |
| Q37689819 | Derivation of human decidua-like cells from amnion and menstrual blood |
| Q41639666 | Differential developmental competence and gene expression patterns in buffalo (Bubalus bubalis) nuclear transfer embryos reconstructed with fetal fibroblasts and amnion mesenchymal stem cells |
| Q34956358 | Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction |
| Q34424242 | Dystrophin conferral using human endothelium expressing HLA-E in the non-immunosuppressive murine model of Duchenne muscular dystrophy |
| Q37210002 | Electrospun Poly(l-lactide)/Poly(ethylene glycol) Scaffolds Seeded with Human Amniotic Mesenchymal Stem Cells for Urethral Epithelium Repair |
| Q30564783 | Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function |
| Q41771482 | Evidence for Transfer of Membranes from Mesenchymal Stem Cells to HL-1 Cardiac Cells |
| Q42585301 | Fetal cell microchimerism in the maternal heart: baby gives back |
| Q36089708 | Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia |
| Q35063280 | Glycome diagnosis of human induced pluripotent stem cells using lectin microarray |
| Q37811950 | HLA-G in organ transplantation: towards clinical applications |
| Q36367004 | Human Amnion-Derived Mesenchymal Stem Cells Promote Osteogenic Differentiation in Human Bone Marrow Mesenchymal Stem Cells by Influencing the ERK1/2 Signaling Pathway. |
| Q36693825 | Human Amnion-Derived Mesenchymal Stem Cells Protect Human Bone Marrow Mesenchymal Stem Cells against Oxidative Stress-Mediated Dysfunction via ERK1/2 MAPK Signaling |
| Q45342933 | Human Amnion-Derived Stem Cells Have Immunosuppressive Properties on NK Cells and Monocytes |
| Q42024223 | Human Amniotic Membrane Mesenchymal Stem Cells inhibit Neutrophil Extracellular Traps through TSG-6. |
| Q26998695 | Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications |
| Q42469036 | Human amnion mesenchymal stem cells promote proliferation and osteogenic differentiation in human bone marrow mesenchymal stem cells. |
| Q60938906 | Human amnion-derived mesenchymal stem cells promote osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity |
| Q36093158 | Human amniotic fluid stem cell preconditioning improves their regenerative potential |
| Q53381073 | Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression. |
| Q37645132 | Hypoxia enhances protective effect of placental-derived mesenchymal stem cells on damaged intestinal epithelial cells by promoting secretion of insulin-like growth factor-1. |
| Q37490948 | Improvement of Heart Failure by Human Amniotic Mesenchymal Stromal Cell Transplantation in Rats |
| Q44786810 | In vitro biological and mechanical evaluation of various scaffold materials for myocardial tissue engineering |
| Q39034662 | Is Immune Modulation the Mechanism Underlying the Beneficial Effects of Amniotic Cells and Their Derivatives in Regenerative Medicine? |
| Q39633236 | Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration |
| Q35030040 | Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. |
| Q38009276 | Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms |
| Q64105453 | Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure |
| Q26748751 | Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015) |
| Q53160097 | Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats. |
| Q37512295 | Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. |
| Q37808269 | Molecular physiology of cardiac regeneration |
| Q48132416 | Neural stem-like cells derived from human amnion tissue are effective in treating traumatic brain injury in rat. |
| Q38005087 | Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. |
| Q34991991 | Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone |
| Q38097512 | Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration. |
| Q38035445 | Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. |
| Q50042214 | Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review |
| Q47631245 | Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure |
| Q84303950 | Stem cells and cell therapies in lung biology and lung diseases |
| Q36176740 | Stem cells in thoracic aortic aneurysms and dissections: potential contributors to aortic repair |
| Q88122166 | The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin |
| Q30458718 | The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function |
| Q84857807 | The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells |
| Q52667755 | Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure. |
| Q41180607 | Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice |
| Q38163605 | Therapeutic potential of placenta-derived stem cells for liver diseases: current status and perspectives |
| Q37887539 | Tissue engineering and cell-based therapy toward integrated strategy with artificial organs |
| Q35098718 | Transcriptional profiling reveals crosstalk between mesenchymal stem cells and endothelial cells promoting prevascularization by reciprocal mechanisms |
| Q33822241 | Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse |
Search more.